Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studies

• Автори: Khalid Alhazzani (Автор), Meshal Alsahli (Автор), Ahmed Z Alanazi (Автор), Mohammad Algahtani (Автор), Ahmad A Alenezi (Автор), Ali Alhoshani (Автор), Mohammed Alqinyah (Автор), Abdullah S. Alhamed (Автор), Khaled Alhosaini (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2023-10-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Non-small cell lung carcinoma is a challenging disease worldwide. This study aims to determine whether combining erlotinib, an epidermal growth factor receptor (EGFR) inhibitor, with cabozantinib, a mesenchymal-epithelial transition factor (c-Met) inhibitor, would have an augmented therapeutic benef...